Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP67057.RAAFae7Xzv3OvOIA2uzK_oZaY07YNfKWvk7y4l0yrpsH4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP67057.RAAFae7Xzv3OvOIA2uzK_oZaY07YNfKWvk7y4l0yrpsH4130_assertion type Assertion NP67057.RAAFae7Xzv3OvOIA2uzK_oZaY07YNfKWvk7y4l0yrpsH4130_head.
- NP67057.RAAFae7Xzv3OvOIA2uzK_oZaY07YNfKWvk7y4l0yrpsH4130_assertion description "[Screening for factor V Leiden and prothrombin G20210A, with prolonged prophylaxis of double carriers, is cost-effective in most patients with VTE.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP67057.RAAFae7Xzv3OvOIA2uzK_oZaY07YNfKWvk7y4l0yrpsH4130_provenance.
- NP67057.RAAFae7Xzv3OvOIA2uzK_oZaY07YNfKWvk7y4l0yrpsH4130_assertion evidence source_evidence_literature NP67057.RAAFae7Xzv3OvOIA2uzK_oZaY07YNfKWvk7y4l0yrpsH4130_provenance.
- NP67057.RAAFae7Xzv3OvOIA2uzK_oZaY07YNfKWvk7y4l0yrpsH4130_assertion SIO_000772 11435632 NP67057.RAAFae7Xzv3OvOIA2uzK_oZaY07YNfKWvk7y4l0yrpsH4130_provenance.
- NP67057.RAAFae7Xzv3OvOIA2uzK_oZaY07YNfKWvk7y4l0yrpsH4130_assertion wasDerivedFrom gad-20130706 NP67057.RAAFae7Xzv3OvOIA2uzK_oZaY07YNfKWvk7y4l0yrpsH4130_provenance.
- NP67057.RAAFae7Xzv3OvOIA2uzK_oZaY07YNfKWvk7y4l0yrpsH4130_assertion wasGeneratedBy ECO_0000203 NP67057.RAAFae7Xzv3OvOIA2uzK_oZaY07YNfKWvk7y4l0yrpsH4130_provenance.